Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$34.22
-2.16%
Mkt Cap $2.09B
Analyst Ratings
Buy
12
Hold
4
Sell
0
Price Target (25 analysts)
$41.67
Range $32.00 – $52.00
Implied Upside
+21.8%
Consensus $41.67 vs current $34.22
NASDAQ·Healthcare·Biotechnology
$34.22
-2.16%
Mkt Cap $2.09B
Buy
12
Hold
4
Sell
0
Price Target (25 analysts)
$41.67
Range $32.00 – $52.00
+21.8%
Consensus $41.67 vs current $34.22